In vivo experiment showed that inoculation of eukaryotic elongation factor 2-knockdown liver cancer cells into mouse front legs suppresses EC proliferation and tube formation via reducing the protein level of KLF5 and preventing KLF5 binding to the VEGF promoter (Zhou et al., 2019). This evidence concerns the gene KLF5 and liver cancer.